Results 151 to 160 of about 6,419 (213)

Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: a multicenter, retrospective, cohort study. [PDF]

BMC Infect Dis
Rao B, Wang D, Yang M, Zhao C, Cheng M, Li S, Zhang D, Luo H, Qian G, Wang L, Zhang S, Li G, Li G, Yu Z, Ren Z.   +14 more
europepmc   +1 more source

Risk Factors for Seeking Medical Care Following Nirmatrelvir-Ritonavir (Paxlovid) Treatment for COVID-19: "Symptom Rebound". [PDF]

Viruses
Bhargava A, Szpunar S, Sharma M, Saravolatz L.   +3 more
europepmc   +1 more source

The unprecedented Paxlovid journey from milligrams to millions of patient doses during the Covid-19 pandemic. [PDF]

Commun Med (Lond)
Yu W, Krishnan MK, Weekly M, Shanker RM, Doshi P, Ragan JA, Greene RA, Gampper B, Caron S, McKillop A, Ludwig J, Dolsten M.   +11 more
europepmc   +1 more source

Genetic Predictors of Paxlovid Treatment Response: The Role of IFNAR2, OAS1, OAS3, and ACE2 in COVID-19 Clinical Course. [PDF]

J Pers Med
Buchynskyi M, Kamyshna I, Halabitska I, Petakh P, Oksenych V, Kamyshnyi O.   +5 more
europepmc   +1 more source

Advances in the effectiveness and safety of azvudine treatment: a comprehensive review. [PDF]

Front Pharmacol
Li J, Zhu B, Lu J, Dong Z, Li P, Li W, Zheng C, Chang J, Shang S.   +8 more
europepmc   +1 more source

Drug-Drug Interactions Leading to Tacrolimus Toxicity in a Renal Transplant Patient With COVID-19: The Role of Paxlovid and the Mitigating Use of Phenytoin. [PDF]

Cureus
Pagan Santini RA, Nair V, Berlinrut I, Nair G, Bhaskaran M.   +4 more
europepmc   +1 more source

Multi-omics and machine learning identify novel biomarkers and therapeutic targets of COVID-19. [PDF]

Front Immunol
Zhou Y, Fan P, Zhang H, Han S, Bai M, Wang J, Wang Q.   +6 more
europepmc   +1 more source

Geospatial Disparities in Federal COVID-19 Test-to-Treat Program [PDF]

Oakley, Erin M., MPH, Smith, Emily R., ScD, MPH   +1 more
core   +1 more source

Acute kidney injury and tacrolimus toxicity in a kidney transplant recipient treated with nirmaltrevir/ritonavir: a case report. [PDF]

J Med Case Rep
Rycen J, Jefferis J, Mudge D.
europepmc   +1 more source

Successful Use of Sulbactam-Durlobactam in Treating Carbapenem-Resistant Acinetobacter baumannii Pneumonia and Sepsis After Liver Transplantation: A Case Report. [PDF]

Am J Case Rep
Xiong HF, Zhang WT, Liu Y, Hou F, Liu B, Cui TT, He ZY, Zhang X, Zhao R, Sun LY.   +9 more
europepmc   +1 more source